Thyroid hormone therapy for nodular goiter, for cosmetic reasons or to avoid diagnostic and therapeutic surgery, results in moderate to complete regression of the nodule.[3] Thyroxine suppressive therapy is an appropriate alternative as long as the patient is followed-up carefully at 6-month intervals.[11] It is prescribed in doses sufficient to suppress the TSH level to 0.1–0.5 μU/ml for 6–12 months; more prolonged therapy is reserved for patients in whom decrease in nodule size is documented on USG. Here, TG is linked to nodular goiter.